|
COPYRIGHT 2005 International Medical News Group
NEW ORLEANS -- Metabolic syndrome raises the risk of adverse outcomes following percutaneous intervention, Vidyasagar Kalahasti, M.D., reported at the annual scientific sessions of the American Heart Association.
This new finding is consistent with previous reports saying patients with metabolic syndrome have higher mortality after coronary artery bypass surgery,...
Read the full article for free courtesy of your local library.
|